Antihypertensive activity of N-[(S)-1-(ethoxycarbonyl)-3-phenylpropyl]-L-Ala-L-Pro (MK-421), an orally active converting enzyme inhibitor

J Pharmacol Exp Ther. 1981 Mar;216(3):558-66.
No abstract available

MeSH terms

  • Administration, Oral
  • Angiotensin I / antagonists & inhibitors
  • Angiotensin-Converting Enzyme Inhibitors*
  • Animals
  • Antihypertensive Agents / pharmacology*
  • Antihypertensive Agents / therapeutic use
  • Blood Pressure / drug effects
  • Dipeptides / pharmacology*
  • Disease Models, Animal
  • Dogs
  • Drug Therapy, Combination
  • Enalapril
  • Female
  • Hydrochlorothiazide / therapeutic use
  • Hypertension / drug therapy
  • Hypertension, Renal / drug therapy
  • Male
  • Nephrectomy
  • Rats
  • Renin / blood

Substances

  • Angiotensin-Converting Enzyme Inhibitors
  • Antihypertensive Agents
  • Dipeptides
  • Hydrochlorothiazide
  • Enalapril
  • Angiotensin I
  • Renin